[Algorithmic analysis of potential drug-drug interactions using direct-acting antiviral agents and concomitant medications in chronic hepatitis C]. [PDF]
Zhonghua Gan Zang Bing Za Zhi, 2018 Wang Q, Rao HY, Wei L.
europepmc +1 more source
[Liver cancer treatment with mitochondrial homeostasis]. [PDF]
Zhonghua Gan Zang Bing Za ZhiSong MF, Ma LY, Shen C, Zhao Q, Zhao CY.
europepmc +1 more source
[Consensus on management of drug-drug interaction with direct-acting antiviral agents in chronic hepatitis C]. [PDF]
Zhonghua Gan Zang Bing Za Zhi, 2018 Chinese Foundation for Hepatitis Prevention and Control +4 more
europepmc +1 more source
[Determination of 145 pharmaceuticals and personal care products in eleven categories in water by ultra-high performance liquid chromatography-triple quadrupole mass spectrometry]. [PDF]
Se PuSun H +5 more
europepmc +1 more source
[Guidelines for the prevention and treatment of metabolic dysfunction-associated (non-alcoholic) fatty liver disease (Version 2024)]. [PDF]
Zhonghua Gan Zang Bing Za ZhiChinese Society of Hepatology +1 more
europepmc +1 more source
[Occurrence risk of extrahepatic liver tumor with hepatitis B virus infection]. [PDF]
Zhonghua Gan Zang Bing Za ZhiZhao DL, Wei L.
europepmc +1 more source
Role and mechanism of endoplasmic reticulum stress and NLRP3 inflammasome in acute kidney injury. [PDF]
Zhong Nan Da Xue Xue Bao Yi Xue BanPei M, Deng K, Chen Y.
europepmc +1 more source
[The application of non-selective β-blockers, angiotensin receptor antagonists and statins in liver cirrhotic patients]. [PDF]
Zhonghua Gan Zang Bing Za Zhi, 2019 Zhang XX, Guo JS.
europepmc +1 more source
Part II Supply: Strategy of Firms. Chapter 4 Pricing Strategy: Theoretical Analysis, Data and Case Study [PDF]
, 2007 Mriko Watanebe
core +1 more source